Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0002064832-25-000063

Chief Business Officer sold 1,394 shares at $14.23 ($19,837)

From the SEC's structured data for this filing

Trades in this filing

Luu Brendan · Chief Business Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-12-05 Sale : show line 1 in the form −1,394 $14.23 $19,837 38,329 D
Open-market sales · 1,394 sh · avg $14.23 · $19,837
Loading xslF345X05/form4.xml…